Back to Trades
Grant4
Cigna Group
CI
Total Value
$15.2M
Company Information
- Company Name
- Cigna Group
- Ticker Symbol
- CI
- CIK
- 0001739940
Insider Information
- Name
- Cordani David
- Role
- Chairman & CEO, Director
- Location
- BLOOMFIELD, CT
DirectorOfficer
Filing Details
- Filing Date
- Mar 3, 2026
- Transaction Date
- Feb 27, 2026
- Accession Number
- 0001739940-26-000009
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock, $.01 Par Value | 23,788 | — | Grant/Award | — |
| Feb 27, 2026 | Common Stock, $.01 Par Value | 17,389 | — | Grant/Award | — |
| Feb 27, 2026 | Common Stock, $.01 Par Value | 11,024 | $287.55 | Tax Withholding | $3.2M |
| Feb 27, 2026 | Common Stock, $.01 Par Value | 4,408 | $287.55 | Tax Withholding | $1.3M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Derivative | 37,516 | $287.55 | Grant/Award | $10.8M |
Footnotes
- (F1)The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2023-2025 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
- (F2)These restricted shares vest in three equal annual installments beginning March 1, 2027.
- (F3)Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
- (F4)Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
- (F5)Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
- (F6)This option vests in three equal annual installments beginning March 1, 2027.